WuXi AppTec, Research Service Division

Enabling Unbounded Possibilities The WuXi AppTec Research Services Division (RSD) supports its clients in the discovery and development of future therapeutics. Through comprehensive discovery and technology platforms, peer-recognised scientific leadership and expertise in oncology, immunology, infectious disease, neurosciences, fibrosis, cardiovascular and metabolic disease, RSD works collaboratively to rapidly advance programs from target through to preclinical selection and beyond. RSD’s discovery platform encompasses biology, chemistry, structural biology and biophysics, in addition to the capabilities of newly acquired HD Biosciences (HDB), and is trusted by over 1,900 international clients, ranging from pharma and biotech to academia and non-profit institutions. This integration of capabilities allows a collaborative environment with closer points of contact for our partners and discovery teams, enabling us to enhance efficiency and productivity. WuXi strives to continually develop and enhance its scientific capabilities and technology to maintain its industry leading position. We aim to provide outstanding services to our existing partners and to the broader discovery community!